| 1 |
34655046 | Aberrant H19 Expression Disrupts Ovarian Cyp17 and Testosterone Production and Is Associated with Polycystic Ovary Syndrome in Women. | 2022 Apr |
2 |
| 2 |
33436964 | Gene expression and functional abnormalities in XX/Sry Leydig cells. | 2021 Jan 12 |
1 |
| 3 |
34333840 | Warning against second-generation antiandrogen for metastatic castration sensitive prostate cancer. | 2021 Nov |
1 |
| 4 |
32712140 | Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy. | 2020 Nov |
1 |
| 5 |
29438723 | Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1. | 2019 Sep |
1 |
| 6 |
29438521 | Leydig cell dysfunction is associated with post-transcriptional deregulation of CYP17A1 in men with Sertoli cell-only syndrome. | 2018 Apr 1 |
2 |
| 7 |
29951171 | A Study on the Clinical Outcome of Abiraterone Acetate in Castration Resistant Prostate Cancer Patients. | 2018 Jan 1 |
1 |
| 8 |
28179152 | The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line. | 2017 Jun |
1 |
| 9 |
28978327 | Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial. | 2017 Oct 4 |
2 |
| 10 |
26626779 | Effects of Nandrolone Stimulation on Testosterone Biosynthesis in Leydig Cells. | 2016 Jun |
1 |
| 11 |
25208301 | Association of CYP17A1 gene -34T/C polymorphism with polycystic ovary syndrome in Han Chinese population. | 2015 Jan |
1 |
| 12 |
25929975 | The CYP17 MspA1 Polymorphism and the Gender Dysphoria. | 2015 Jun |
1 |
| 13 |
26150586 | Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment Paradigms. | 2015 Jul |
2 |
| 14 |
26770559 | Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. | 2015 |
2 |
| 15 |
24140493 | The polymorphism (-600 C>A) of CpG methylation site at the promoter region of CYP17A1 and its association of male infertility and testosterone levels. | 2014 Jan 15 |
1 |
| 16 |
25153259 | Molecular adaptations of testosterone-producing Leydig cells during systemic in vivo blockade of the androgen receptor. | 2014 Oct |
1 |
| 17 |
25629114 | Re: the polymorphism (-600 C>A) of CpG methylation site at the promoter region of CYP17A1 and its association of male infertility and testosterone levels. | 2014 Jul |
1 |
| 18 |
23337755 | Agents that target androgen synthesis in castration-resistant prostate cancer. | 2013 Jan-Feb |
1 |
| 19 |
23628604 | SET/PP2A system regulates androgen production in ovarian follicles in vitro. | 2013 Jul 15 |
2 |
| 20 |
24223995 | Endurance exercise and conjugated linoleic acid (CLA) supplementation up-regulate CYP17A1 and stimulate testosterone biosynthesis. | 2013 |
2 |
| 21 |
22123334 | Abiraterone acetate in castration-resistant prostate cancer. | 2012 Mar |
1 |
| 22 |
22174412 | Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cells. | 2012 Feb 3 |
1 |
| 23 |
22184395 | Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone. | 2012 Feb 20 |
1 |
| 24 |
22198164 | Abiraterone acetate: redefining hormone treatment for advanced prostate cancer. | 2012 Mar |
1 |
| 25 |
22430753 | [Abiraterone acetate: a novel therapeutic option in hormone-refractory prostate cancer]. | 2012 Feb |
1 |
| 26 |
22451619 | Abiraterone in prostate cancer: a new angle to an old problem. | 2012 Apr 1 |
2 |
| 27 |
22752297 | Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer. | 2012 Aug |
1 |
| 28 |
21511288 | Hypospadias risk and polymorphism in SRD5A2 and CYP17 genes: case-control study among Indian children. | 2011 Jun |
1 |
| 29 |
21676446 | Polymorphisms in the P450 c17 (17-hydroxylase/17, 20-Lyase) gene: association with estradiol and testosterone concentration in hypospadias. | 2011 Oct |
1 |
| 30 |
21948762 | Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey. | 2011 Sep 9 |
1 |
| 31 |
21985170 | Abiraterone acetate: in metastatic castration-resistant prostate cancer. | 2011 Oct 22 |
1 |
| 32 |
17326004 | Sexual hormones in human skin. | 2007 Feb |
1 |
| 33 |
16103457 | Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta. | 2005 Aug |
1 |
| 34 |
14560315 | Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2. | 2004 Apr |
1 |
| 35 |
15477877 | Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk. | 2004 |
2 |
| 36 |
12915666 | The 17, 20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway. | 2003 Aug |
1 |
| 37 |
14522586 | 5alpha-reduced C21 steroids are substrates for human cytochrome P450c17. | 2003 Oct 15 |
1 |
| 38 |
11895872 | A polymorphism in the CYP17 gene and risk of prostate cancer. | 2002 Mar |
2 |
| 39 |
11303586 | The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. | 2001 Mar |
1 |
| 40 |
11341336 | A common promotor variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability testosterone levels and bone size in men. | 2001 May |
2 |
| 41 |
9858495 | Development and differentiation of the interstitial and tubular compartments of fetal porcine testes. | 1999 Jan |
2 |
| 42 |
9794458 | Regulation of 3beta-hydroxysteroid dehydrogenase in gonadotropin-induced steroidogenic desensitization of Leydig cells. | 1998 Nov |
1 |
| 43 |
9863627 | Time-course effects of human recombinant luteinizing hormone on porcine Leydig cell specific differentiated functions. | 1998 Sep 25 |
1 |